A. Quality Assurance
A mechanism for valid peer review must be established
and ongoing at each institution performing PCI. Interventional
cardiology procedures are associated with complications
that in general are inversely related to operator and
institutional volume (43,180-183).
The mechanism for institutional review should provide
an opportunity for interventionalists as well as physicians
who do not perform angioplasty, but are knowledgeable
about it, to review overall results of the program on
a regular basis. The responsible supervising authority
should monitor the following issues as outlined in Table
12.
The institutional credentialing committee should document
that an interventionalist wishing to start practice
meets the established training criteria, including those
of the ACC Task Force on Training in Cardiac Catheterization
and Interventional Cardiology (21,185,186).
The ACC Training Statement (186)
for coronary invasive training requires a 3-year comprehensive
cardiac program with 12 months of training in diagnostic
catheterization during which the trainee performs 300
diagnostic catheterizations with 200 of those being
the primary operator. The interventional training requires
a fourth year of fellowship during which the trainee
should perform more than 250 interventional procedures,
but not more than 600 per year (186).
To be eligible for the American Board of Internal Medicine
(ABIM) certifying examination in interventional cardiology,
a trainee must be actively involved in at least 250
interventional procedures during a 4th year of interventional
cardiology fellowship. Only one trainee may receive
credit for the intervention on a given patient. Until
2003, the practicing interventionalist can qualify for
the examination by active involvement in interventional
cardiology, including the performance of at least 150
interventions over the prior 2 year period (187).
Credentials committees should evaluate the physicians
outcomes to be certain that volume and results meet
the current standards or benchmarks for successful management
(21).
These benchmarks refer to procedural rates of unadjusted
mortality (0.9%) and emergency coronary artery bypass
surgery (
3.0%).
It should be noted that these benchmarks are derived
from PTCA performed in New York State on all procedures
including those for complicated acute MI and that they
were gathered before the use of stents and platelet
GP IIb/IIIa inhibitors. Thus, the standard for benchmark
complication rates will be subject to future revision
as newer data emerge. It is important that institutions
assist with these efforts by participating in active
database efforts to track clinical and procedural information
for individual operators amd their institutions. In
the future, certification by the ABIM in Interventional
Cardiology should be required.
This Writing Committee agrees with the ACC Task Force
recommendations for the Assessment and Maintenance of
Proficiency in Coronary Interventional Procedures (21).
Institutions performing PCI should meet the following
standards as outlined in Tables
13 and 14 (21,184,186).
B. Operator and Institutional
Volume
The proliferation of small angioplasty or small surgical
programs to support such angioplasty programs is strongly
discouraged. Several studies have identified procedural
volume as a determining factor for frequency of complications
with PCI (43,182,183,188-191).
Kimmel, using data from the Society of Cardiac Angiography
and Interventions (SCA&I), found that an inverse relationship
existed between the number of angioplasty procedures
performed at a hospital and the rate of major complications
(181).
These results were risk-stratified and independent of
the patient-risk profile. Significantly fewer complications
occurred in laboratories performing
400
angioplasty procedures per year. Conversely, low-volume
hospitals were associated with higher rates of emergency
coronary artery bypass surgery and death (182).
Improved outcomes were identified with a threshold volume
of 75 Medicare angioplasties per physician and 200 Medicare
angioplasty procedures per hospital. Using a 35 to 50%
ratio of Medicare patients, the threshold value was
150 to 200 angioplasty procedures per cardiologist and
400 to 600 angioplasty procedures per institution (40).
Other studies have also supported the relationship of
complications to procedural volume (43,180,183).
Although some investigators have suggested that low
procedure volume does not contribute to poor outcomes
(188,192),
these studies are small in number and underpowered for
analysis (189).
Development of small cardiovascular surgical programs
to support angioplasty is a poor use of resources that
will likely lead to suboptimal results (190).
Given the concerns regarding operator volume and surgical
standby, it is recommended that PCI be performed by
higher volume operators (
75
cases/year) with advanced technical skills (e.g., subspecialty
certification) at institutions with fully equipped interventional
laboratories and experienced support staff. This setting
will most often be in a high-volume center (>400 cases/year)
associated with an on-site cardiovascular surgical program
(193).
Similar concerns have been identified and supported
by the Task Force for Practice Guidelines for Coronary
Angiography (194).
Intuitively, it is clear that it would be best for
the rare patient requiring surgery after elective PCI
to remain in the same hospital rather than have the
patient and family undergo the confusion, stress, and
anxiety of emergency transfer. Given the widespread
availability of sophisticated interventional/surgical
programs in the United States, it is difficult to demonstrate
a need for additional low-volume programs to do elective
angioplasty except in underserved areas that are geographically
far removed from major centers. This Committee acknowledges
that not every cardiologist desiring to do PCI should
perform these procedures and not every hospital anxious
to have an interventional program should start one (191).
This caveat is particularly true where there are high-volume
programs and operators nearby. In these situations,
operators should be subspecialty board certified.
The Committee, therefore, recommends that angioplasty
is best done by high-volume operators in high-volume
institutions. Any change in this recommendation awaits
further data confirming the comparable safety and outcomes
for patients treated in an alternative manner. The Committee
cannot recommend angioplasty by low-volume operators
(<75 cases/year) working in low-volume institutions
(<200 cases/year) with or without on-site surgical coverage.
As noted earlier, ongoing investigational experience
and clinical data are mandatory if these recommendations
are to be modified.
Recommendations for PCI Institutional and Operator
Volumes at Centers With Onsite Cardiac Surgery (21,186)
(Table 14)
Class I
1. PCI done by operators with acceptable volume
(
75)
at high-volume centers (>400). (Level of Evidence:
B)
Class IIa
1. PCI done by operators with acceptable volume
(
75)
at low-volume centers (200-400). (Level of Evidence:
C)
2. PCI done by low-volume operators (<75) at high-volume
centers (>400). Note: Ideally operators with an annual
procedure volume <75 should only work at institutions
with an activity level of >600 procedures/year.* (Level
of Evidence: C)
Class III
1. PCI done by low-volume operators (<75) at
low-volume centers (200-400). Note: An institution with
a volume <200 procedures/year, unless in a region that
is underserved because of geography, should carefully
consider whether it should continue to offer service.*
(Level of Evidence: C)
*Operators who perform <75 procedures/year
should develop a defined mentoring relationship with
a highly experienced operator who has an annual procedural
volume >150 procedures/year.
C. On-Site Cardiac Surgical
Backup
Cardiac surgical backup for PCI has evolved from the
formal surgical standby in the 1980s to an informal
arrangement of first available operating room and, in
some cases, off-site surgical backup (40,195-199).
With the advent of intracoronary stenting, there has
been a decrease in the need for emergency coronary artery
bypass, ranging between 0.4 and 2% (200-202).
Not surprisingly, emergency coronary artery bypass for
a patient with an occluded or dissected coronary artery
is associated with a higher mortality than elective
surgery (203-208).
Emergency procedures are also associated with high rates
of perioperative infarction and less frequent use of
arterial conduits. Complex CAD intervention, hemodynamic
instability, and prolonged time to reperfusion are contributing
factors to the increased risk of emergency bypass surgery.
1. Primary PCI Without On-Site
Cardiac Surgery. Although thrombolytic trials demonstrated
that early reperfusion saves myocardium and reduces
mortality (209-212),
the superiority and greater applicability of primary
PCI for the treatment of acute MI has raised the question
of whether primary PCI should be performed at institutions
with diagnostic cardiac catheterization laboratories
that do not perform elective PCI or have on-site cardiac
surgery. For this reason, the establishment of PCI programs
at institutions without on-site cardiovascular surgery
has been promoted as necessary to maintain quality of
care (195-197,213-220).
In those patients where there is a contraindication
to thrombolytic therapy, or when there are complications
such as cardiogenic shock, catheter-based therapy may
limit infarct size (221,222).
It must be realized that PCI in the early phase of an
acute MI can be difficult and requires even more skill
and experience than routine PCI in the stable patient.
The need for an experienced operator and experienced
laboratory technical support (223)
with availability of a broad range of catheters, guidewires,
stents, and other devices (e.g., IABP) that are required
for optimum results in an acutely ill patient is of
major importance (Table 15).
If these complex patients are treated by interventionalists
with limited experience at institutions with low volume,
then the gains of early intervention may be lost because
of increased complications. In such circumstances, transfer
to a center that routinely performs complex PCI will
often be a more effective and efficient course of action
(16).
Thrombolysis is still an acceptable form of therapy
(224)
and is preferable to acute PCI by an inexperienced team
(224,225).
Reports of emergency primary angioplasty programs from
hospitals without established open-heart surgery or
elective angioplasty, similar to those of most tertiary
centers, have demonstrated generally favorable results.
Such acceptable clinical results have been reported
with intensive training, continuous oversight, and the
combination of nearby, readily available bypass surgery
support, a team of highly experienced interventionalists
and support staff, and careful patient selection (214).
However, poor results of similar endeavors are rarely
reported. Before the use of stenting and glycoprotein
receptor blockers, primary angioplasty in certain hospitals
has been associated with acute mortality rates greater
than those reported from centers with established primary
angioplasty programs. Overall, in-hospital mortality
rates have ranged from 1.4 to 13% (196,197,216).
Criteria have been suggested for the performance of
primary PCI at hospitals without on-site cardiac surgery
(Tables 15 and 16).
Of note, large-scale registries have shown an inverse
relationship between the number of primary angioplasty
procedures performed and in-hospital mortality (226-228).
The data suggest that both door-to-balloon time and
in-hospital mortality are significantly lower in institutions
performing more than 36 primary angioplasty procedures
per year (229).
Communities may identify a unique qualified and experienced
center wherein the on-site intervention for acute MI
could be performed. Suboptimal results may relate to
operator/staff inexperience and capabilities and delays
in performing angioplasty for logistical reasons (230).
From clinical data and expert consensus, the Committee
recommends that primary PCI for acute MI performed at
hospitals without established elective PCI programs
should be restricted to those institutions capable of
performing a requisite minimum number of primary angioplasty
procedures (36 per year) with a proven plan for rapid
and effective PCI as well as rapid access to cardiac
surgery in a nearby facility (193)
(Table 17).
2. Elective PCI Without On-Site
Surgery. Technical improvements in interventional
cardiology have led to the development of elective angioplasty
programs without on-site surgical coverage. Several
centers have reported satisfactory results based on
careful case selection with well-defined arrangements
for immediate transfer to a surgical program (195-199,231-235).
The studies of angioplasty without on-site surgical
coverage have not identified significant differences
in the outcomes, recalling the infrequent rate of complications
(236).
Despite many reported successful angioplasty series
without on-site surgical backup and a very low percentage
need for off-site surgery in failed angioplasty, some
clinicians have expressed concern (237,238)
about the appropriateness of elective angioplasty in
centers without on-site surgical coverage. Caution is
warranted before endorsing an unrestricted policy for
PCI in hospitals without appropriate facilities. Several
outstanding and critically important clinical issues,
such as timely management of ischemic complications,
adequacy of specialized post-interventional care, logistics
for managing cardiac surgical or vascular complications
and operator/laboratory volumes, and accreditation must
be addressed. Mere convenience should not replace safety
and efficacy in establishing an elective PCI program
without on-site surgery.
At this time, the Committee, therefore, continues to
support the recommendation that elective PCI should
not be performed in facilities without on-site cardiac
surgery (Table 17). As with
many dynamic areas in interventional cardiology, these
recommendations may be subject to revision as clinical
data and experience increase.
Recommendations for PCI With and Without On-Site
Cardiac Surgery (Table 17)
Class I
1. Patients undergoing elective PCI in facilities
with on-site cardiac surgery. (Level of Evidence:
B)
2. Patients undergoing primary PCI in facilities
with on-site cardiac surgery. (Level of Evidence:
B)
Class IIb
1. Patients undergoing primary PCI in facilities
without on-site cardiac surgery, but with a proven plan
for rapid access (within 1 h) to a cardiac surgery operating
room in a nearby facility with appropriate hemodynamic
support capability for transfer. The procedure should
be limited to patients with ST-segment elevation MI
or new LBBB on ECG, and done in a timely fashion (balloon
inflation within 90 ± 30 min of admission) by persons
skilled in the procedure (
75
PCIs/year) (193)
and only at facilities performing a minimum of 36 primary
PCI procedures per year (229).
(Level of Evidence: B)
Class III
1. Patients undergoing elective PCI in facilities without
on-site cardiac surgery. (Level of Evidence: C)
2. Patients undergoing primary PCI in facilities
without on-site cardiac surgery and without a a proven
plan for rapid access (within 1 h) to a cardiac surgery
operating room in a nearby facility with appropriate
hemodynamic support capability for transfer or when
performed by lower skilled operators (<75 PCIs per year)
in a facility performing <36 primary PCI procedures
per year. (Level of Evidence: C)